Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Vineet Laboratories Ltd

NSE: VINEETLAB · BSE: 543298 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹36.82
Market cap
₹70.72 Cr
Revenue (annual)
₹59.40 Cr
Net profit (annual)
₹1.11 Cr
P/E (TTM)
63.7×Sector 47.4×
Promoter holding
5.98%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:06 IST BSE
Other Announcement

Vineet Laboratories Other Announcement

Vineet Laboratories received an extension from the Registrar of Companies, Hyderabad, to hold its 10th Annual General Meeting by 30th November 2026.

18:23 IST BSE
Board Meeting Date

Vineet Laboratories Board Meeting Date

Vineet Laboratories Limited scheduled a board meeting for August 25, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.

18:59 IST BSE
Other Announcement

Vineet Laboratories Other Announcement

Vineet Laboratories filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming the utilization of Rights Issue proceeds as per the offer document.

Value
₹29.97 Cr
23:18 IST NSE
Other Announcement

Vineet Laboratories Other Announcement

Vineet Laboratories Limited submitted a certificate declaring non-applicability of Corporate Governance provisions for the quarter ended June 30, 2026, due to meeting regulatory threshold exemptions.

21:58 IST BSE
Management Change

Vineet Laboratories Management Change

Vineet Laboratories Limited has appointed Mr. Rajesh Kumar Kathulla as an Additional Director (Executive Category), effective June 11, 2026, subject to shareholder approval.

19:29 IST BSE
Board Meeting Date

Vineet Laboratories Board Meeting Date

Vineet Laboratories scheduled a board meeting on July 15, 2026. The board will consider audited standalone financial results for FY26.

23:01 IST BSE
Board Meeting Outcome

Vineet Laboratories Board Meeting Outcome

Vineet Laboratories deferred approval of its FY26 financial results as the Audit Committee had not yet recommended them. The trading window remains closed until results are declared.

19:26 IST BSE
Management Change

Vineet Laboratories Management Change

Mr. Ramesh Kumar Bandari resigned as Company Secretary and Compliance Officer effective May 29, 2026. This administrative change follows his personal decision to step down.

19:05 IST BSE
Board Meeting Date

Vineet Laboratories Board Meeting Date

Vineet Laboratories scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.

17:11 IST NSE
Other Announcement

Vineet Laboratories Other Announcement

Vineet Laboratories Limited submitted a certificate of non-applicability for Corporate Governance reporting for the quarter ended March 31, 2026. The company is exempt as its paid-up equity capital and net worth remain below the SEBI LODR threshold limits. Management confirmed they will comply if these limits are exceeded in the future.

19:19 IST NSE
Other Announcement

Vineet Laboratories Other Announcement

Vineet Laboratories Limited submitted its quarterly compliance certificate for the Structured Digital Database for the quarter ended March 31, 2026. The company confirmed the database is in place, non-tamperable, and maintained internally with an audit trail. No non-compliances were reported during the period.